The clinical significance of flow cytometric c-myc oncoprotein quantitation in testicular cancer

Open Access

1 March 1986

journal article
research article
Published by Springer Nature in British Journal of Cancer

Vol. 53 (3) , 331-337
https://doi.org/10.1038/bjc.1986.56

Abstract

A sensitive flow cytometric assay has been developed using a monoclonal antibody, Myc 1-6E10, to quantitate c-myc oncoprotein levels in nuclei isolated from wax embedded testicular tumours. The oncoprotein (p62c-myc) level increased significantly with increasing teratoma differentiation. Patients with intermediate and undifferentiated tumours who developed recurrence had lower p62c-myc levels than those who were disease free since their initial treatment. Such quantitative biochemical methods may provide new prognostic indices for cancer patients.

Keywords

This publication has 31 references indexed in Scilit:

c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells
Nature, 1985
Cellular transforming genes and oncogenesis
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1984
GENOMIC ALTERATIONS INVOLVING THE C-MYC PROTO-ONCOGENE LOCUS DURING THE EVOLUTION OF A CASE OF CHRONIC GRANULOCYTIC LEUKAEMIA
The Lancet, 1984
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene
Nature, 1984
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences
Nature, 1984
Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor
Cell, 1983
Amplification and expression of the c-myc oncogene in human lung cancer cell lines
Nature, 1983
The Emerging Genetics of Human Cancer
New England Journal of Medicine, 1983
Cancer genes come of age
Cell, 1983
Altered gene products are associated with activation of cellular rasK genes in human lung and colon carcinomas
Cell, 1983